Contract with Customer, Liability, Noncurrent in USD of ELITE PHARMACEUTICALS INC /NV/ from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly Contract with Customer, Liability, Noncurrent history and change rate from Q1 2021 to Q2 2024.
  • ELITE PHARMACEUTICALS INC /NV/ Contract with Customer, Liability, Noncurrent for the quarter ending 30 Jun 2024 was $2.22K, a 85.7% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.22K -$13.3K -85.7% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $5.56K -$13.3K -70.6% 31 Mar 2024 10-K 30 Jun 2025
Q4 2023 $8.89K -$13.3K -60% 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $12.2K -$13.3K -52.2% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $15.6K -$13.3K -46.2% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $18.9K -$13.3K -41.4% 31 Mar 2023 10-K 01 Jul 2024
Q4 2022 $22.2K -$13.3K -37.5% 31 Dec 2022 10-Q 14 Feb 2023
Q3 2022 $25.6K 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $28.9K 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $32.2K -$13.3K -29.3% 31 Mar 2022 10-K 29 Jun 2023
Q4 2021 $35.6K 31 Dec 2021 10-Q 14 Feb 2022
Q1 2021 $45.6K 31 Mar 2021 10-K 29 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.